http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 03 Sep 2026 04:13:48 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/Alpha+Tau+Medical+Ltd.+%28DRTS%29+PT+Raised+to+%2430+at+Barclays/27021117.html Barclays analyst Lukas Shumway raised the price target on Alpha Tau Medical Ltd. (NASDAQ: DRTS) to $30.00 (from $17.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Alpha+Tau+Medical+Ltd.+%28DRTS%29+PT+Raised+to+%2430+at+Barclays/27021117.html Thu, 03 Sep 2026 04:13:48 -0400 DRTS http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Reiterates+Buy+Rating+on+Alpha+Tau+Medical+Ltd.+%28DRTS%29/27008809.html <p>H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $16.00 price target on Alpha Tau Medical Ltd. (NASDAQ: DRTS).</p><p>The analyst commented: "Yesterday, Alpha Tau Medical announced the completion of enrollment of 48 patients for the IMPACT pilot study of intratumoral Alpha DaRT in combination with first-line chemotherapy in newly diagnosed, unresectable locally advanced or metastatic pancreatic adenocarcinoma. IMPACT is a prospective, multicenter, open-label pilot study evaluating the feasibility, safety and efficacy of intratumoral Alpha DaRT in combination with first-line standard-of-care chemotherapy (either mFOLFIRINOX or gemcitabine in combination with Abraxane (nab-paclitaxel)). The study is conducted under a U.S. IDE and http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Reiterates+Buy+Rating+on+Alpha+Tau+Medical+Ltd.+%28DRTS%29/27008809.html Tue, 01 Sep 2026 07:15:08 -0400 DRTS http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alpha+Tau+Medical+Ltd.++++For%3A+Aug+21++Filed+by%3A+Levy+Raphi/26972627.html si-local-file:///var/storage/secattach/20260825/26972627.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alpha+Tau+Medical+Ltd.++++For%3A+Aug+21++Filed+by%3A+Levy+Raphi/26972627.html Tue, 25 Aug 2026 10:34:00 -0400 DRTS O.49911888 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alpha+Tau+Medical+Ltd.++++For%3A+Aug+21++Filed+by%3A+Levy+Raphi/26972627.html si-local-file:///var/storage/secattach/20260825/26972627.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alpha+Tau+Medical+Ltd.++++For%3A+Aug+21++Filed+by%3A+Levy+Raphi/26972627.html Tue, 25 Aug 2026 10:34:00 -0400 DRTS O.49911888 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Alpha+Tau+Medical+Ltd.+++++++++++++++++Filed+by%3A+Levy+Raphi/26962322.html si-local-file:///var/storage/secattach/20260821/26962322.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Alpha+Tau+Medical+Ltd.+++++++++++++++++Filed+by%3A+Levy+Raphi/26962322.html Fri, 21 Aug 2026 17:01:00 -0400 DRTS O.49911888 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Alpha+Tau+Medical+Ltd.+++++++++++++++++Filed+by%3A+Levy+Raphi/26962322.html si-local-file:///var/storage/secattach/20260821/26962322.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Alpha+Tau+Medical+Ltd.+++++++++++++++++Filed+by%3A+Levy+Raphi/26962322.html Fri, 21 Aug 2026 17:01:00 -0400 DRTS O.49911888 http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html <p>Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.</p> <p>The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.</p> <p>Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS) http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html Mon, 17 Aug 2026 08:01:58 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html <p>Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.</p> <p>The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.</p> <p>Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS) http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html Mon, 17 Aug 2026 08:01:58 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html <p>Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.</p> <p>The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.</p> <p>Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS) http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html Mon, 17 Aug 2026 08:01:58 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html <p>Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.</p> <p>The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.</p> <p>Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS) http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html Mon, 17 Aug 2026 08:01:58 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html <p>Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.</p> <p>The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.</p> <p>Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS) http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html Mon, 17 Aug 2026 08:01:58 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html <p>Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.</p> <p>The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.</p> <p>Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS) http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html Mon, 17 Aug 2026 08:01:58 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html <p>Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.</p> <p>The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.</p> <p>Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS) http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html Mon, 17 Aug 2026 08:01:58 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html <p>Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.</p> <p>The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.</p> <p>Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS) http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html Mon, 17 Aug 2026 08:01:58 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Globe+Newswire/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Globe+Newswire/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Globe+Newswire/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Globe+Newswire/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP http://www.streetinsider.com/Globe+Newswire/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html <p>WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).</p> <p>As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with http://www.streetinsider.com/Globe+Newswire/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html Mon, 17 Aug 2026 08:00:00 -0400 DRTS LFWD NNDM O.05713056 O.13805217 O.49911888 O.56010000 ORMP